ALIDA BIOSCIENCES INC.
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.2Mattributed |
|---|---|
| Latest round | grant, $2.2M, 2023-06-01attributed |
| Founded | 2019 |
| Headquarters | SAN DIEGO, California, USA |
| Industry | bio |
| Stage | unknown |
| Website | alidabio.com |
Alida Biosciences offers EpiPlex, an RNA-modification detection platform (m6A, inosine, pseudouridine) using proximity barcoding and engineered binders. It serves researchers in basic science and diagnostics analyzing epitranscriptomic change. Differentiator: turnkey service + in-lab kits that work on FFPE and RNA-limited inputs.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-06-01 | grant | $2.2M | undisclosed |
Detected tech stack
Nginx, WordPress, Yoast SEO 27.6, Google Analytics, Google Tag Manager, Site Kit 1.179.0, Slick, Jetpack, Plesk, DoubleClick Floodlight, HubSpot, CookieYes
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.2M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.2M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | alidabio.com, read 2026-05-05 |
| Description | self-reported | alidabio.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.